Re-treating prostate cancer radiation to study side effects
Part of Cancer, Injuries & trauma, Kidney & urinary clinical trials.
This study looks at whether re-treating prostate cancer with radiation (after it came back) can be done safely and how side effects affect people. It also checks whether this approach is practical to carry out, especially for urinary side effects and comfort during the process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a man age 18 or older
- Your prostate cancer has come back in the same area after prior radiation, and it’s been at least 2 years since that radiation
- Your cancer does not appear to have spread (no metastases) on scans or exam
- You can have an MRI scan (no intolerance/contraindications) and can manage the study procedures
- Your urinary function is reasonably good: IPSS under 20 and urine flow rate over 10 mL/second
- You’re well enough for daily activities: WHO performance status 0–2, and you’re expected to live more than 10 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This study compares two radiation treatments—seed brachytherapy and stereotactic body radiotherapy—to see which better preserves erections in men with early- to mid-risk prostate cancer. It’s designed to help patients understand how different curative radiation choices can affect sexual function.
This trial compares two types of radiation therapy (SBRT and LDR brachytherapy) for men with low-risk or favorable intermediate-risk prostate cancer. The goal is to see which treatment causes fewer side effects.
This trial tests a high-dose radiation treatment (brachytherapy) that places tiny radioactive seeds directly into the area where your prostate was. It is for men whose prostate cancer has returned only in that area after having their prostate removed.
This study follows people with prostate cancer who receive radiation to understand what side effects and quality-of-life changes happen over time. It may help improve standard follow-up care by better tracking radiation-related toxicity.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.